Research Output per year
Fingerprint Dive into the research topics where Ctr-Simmons Compr. Cancer is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Disclosure
Medicine & Life Sciences
Phosphatidylinositol 3-Kinases
Medicine & Life Sciences
Emotions
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Null Lymphocytes
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Integrins
Medicine & Life Sciences
Joining
Chemical Compounds
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles

Farjana Fattah
- Simmons Comprehensive Cancer Center - ASSISTANT PROFESSOR
- Ctr-Simmons Compr. Cancer - ASSISTANT PROFESSOR
Person: Academic

Ariella Hanker
- Simmons Comprehensive Cancer Center - ASSISTANT PROFESSOR
- Ctr-Simmons Compr. Cancer - ASSISTANT PROFESSOR
Person: Academic

Gang Huang
- Simmons Comprehensive Cancer Center - Assistant Professor
- Ctr-Simmons Compr. Cancer
Person: Academic
Research Output 2014 2019
7
Citations
(Scopus)
Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors
Hanker, A. B., Kaklamani, V. & Arteaga, C. L., Apr 1 2019, In : Cancer discovery. 9, 4, p. 482-491 10 p.Research output: Contribution to journal › Review article
Phosphatidylinositol 3-Kinases
Neoplasms
Drug-Related Side Effects and Adverse Reactions
Patient Selection
Cell Survival
Correction: HER2-overexpressing breast cancers amplify FGFR signaling upon acquisition of resistance to dual therapeutic blockade of HER2(Clin Cancer Res. (2017) 23:15 (4323-4334) DOI: 10.1158/1078-0432.CCR-16-2287)
Hanker, A. B., Garrett, J. T., Valeria Estrada, M., Moore, P. D., Ericsson, P. G., Koch, J. P., Langley, E., Singh, S., Kim, P. S., Frampton, G. M., Sanford, E., Owens, P., Becker, J., Groseclose, M. R., Castellino, S., Joensuu, H., Huober, J., Brase, J. C., Majjaj, S., Brohee, S. & 6 others, , Feb 15 2019, In : Clinical Cancer Research. 25, 4, 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Disclosure
Emotions
Breast Neoplasms
Neoplasms
Therapeutics
Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808)
Hanker, A. B., Estrada, M. V., Bianchini, G., Moore, P. D., Zhao, J., Cheng, F., Koch, J. P., Gianni, L., Tyson, D. R., Sánchez, V., Rexer, B. N., Sanders, M. E., Zhao, Z., Stricker, T. P. & Arteaga, C. L., Feb 15 2019, In : Cancer Research. 79, 4, 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Disclosure
Phosphatidylinositol 3-Kinases
Integrins
Extracellular Matrix
Emotions